^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    GENE:

    ZDHHC22 (Zinc Finger DHHC-Type Palmitoyltransferase 22)

    i
    Other names: ZDHHC22, Zinc Finger DHHC-Type Palmitoyltransferase 22, C14orf59, Zinc Finger DHHC Domain-Containing Protein 22, Zinc Finger DHHC-Type Containing 22, Palmitoyltransferase ZDHHC22, DHHC-22, Zinc Finger, DHHC Domain Containing 22, Putative Palmitoyltransferase ZDHHC22, Chromosome 14 Open Reading Frame 59, ZDHHC22
    Associations

    News

    Trials
    9ms
    Identification of Differentially Expressed Genes in Spinal Cord Injury. (PubMed, Genes (Basel))
    Our findings highlight complex immune and autoimmune responses that contribute to ongoing inflammation and tissue damage post-SCI, underscoring new avenues for therapeutic interventions targeting these molecular processes.
    Journal
    |
    TNFA (Tumor Necrosis Factor-Alpha) • CD68 (CD68 Molecule) • FCGR2A (Fc fragment of IgG receptor IIa) • FCGR2B (Fc Fragment Of IgG Receptor IIb) • ZDHHC22 (Zinc Finger DHHC-Type Palmitoyltransferase 22)
    almost3years
    Research into the characteristic molecules significantly affecting liver cancer immunotherapy. (PubMed, Front Immunol)
    Our results provide novel insights into the DEGs and factors affecting liver cancer immunotherapy. Meanwhile, CDCA7 was identified as a potential therapeutic target in this patient population.
    Journal • IO biomarker
    |
    PRSS3 (Serine Protease 3) • IGFBP1 (Insulin Like Growth Factor Binding Protein 1) • POU2AF1 (POU Class 2 Homeobox Associating Factor 1) • ZDHHC22 (Zinc Finger DHHC-Type Palmitoyltransferase 22)
    over3years
    Palmitoyl transferases act as potential regulators of tumor-infiltrating immune cells and glioma progression. (PubMed, Mol Ther Nucleic Acids)
    Targeting ZDHHCs also promoted the sensitivity of glioma cells to temozolomide (TMZ) chemotherapy...Taken together, our findings suggest that the inhibition of ZDHHCs suppresses glioma-cell viability and microglial infiltration. Targeting ZDHHCs may be promising for glioma treatments.
    Journal
    |
    ZDHHC22 (Zinc Finger DHHC-Type Palmitoyltransferase 22)
    |
    temozolomide